This new indication adds to the prescribing label for Wegovy, a prescription-only medicine previously approved for adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off when used along with a reduced calorie diet and increased physical activity
(Source: ScienceDaily, May 2026) Who Is Using Semaglutide in America in 2026
Lead author Dr Eduardo Grunvald, an obesity expert at the University of California, San Diego, said the recommendation was needed because lifestyle interventions alone do not always work
The recommended dose for this form of magnesium is 144 mg
As a result, beneficiaries with obesity and related conditions have continued to face limited coverage options
The question isn't merely whether the product is unapproved